ProShares Ultra Nasdaq Biotechnology (BIB)
-NasdaqGM 100.18 
1.88(1.91%) May 17, 3:59PM EDT
| Prev Close: | 98.30 |
|---|
| Open: | 100.71 |
|---|
| Bid: | N/A |
|---|
| Ask: | 106.00 x 200 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 98.00 - 100.97 |
|---|
| 52wk Range: | 43.76 - 107.04 |
|---|
| Volume: | 42,676 |
|---|
| Avg Vol (3m): | 38,797 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Biolitec CEO Neuberger Ordered Arrested by U.S. Judgeat Bloomberg(Fri, Apr 12)
- ProShares Launches Listed Private Equity ETFBusiness Wire(Thu, Feb 28)
- ProShares Lowers Net Expense Ratio for CSM, a Morningstar Rated 5-Star ETFBusiness Wire(Thu, Feb 7)
- ProShares Launches First True Merger Arbitrage ETFBusiness Wire(Thu, Dec 13)
- ProShares Announces Zero Capital Gain Distributions for its 117 Equity and Fixed Income ETFsBusiness Wire(Thu, Nov 29)
- Obama Victory Puts Healthcare ETFs In FocusETF Database(Fri, Nov 9)
- Missed Investment Opportunities Of 2012at Investopedia(Thu, Oct 25)
- The Five Top-Performing ETFs of the YearETF Trends(Mon, Oct 15)
- The 5 Best Performing ETFs of 2012 Thus Farat Minyanville(Wed, Oct 10)
- ProShares Sets Share Splits On 11 ETFsIndexUniverse.com(Mon, Sep 24)
- ProShares to Split ETFsETF Trends(Thu, Sep 20)
- 5 Leveraged ETFs With Huge 52 Week ReturnsETF Database(Mon, Sep 10)
- 3 Stocks Near 52-Week Highs Worth Sellingat Motley Fool(Thu, Sep 6)
- Biotech Disaster 101: When The Market Takes A Dive, Biotechs Sink To The Bottomat Seeking Alpha(Wed, Jun 6)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|